2025-07-25 - Analysis Report
Okay, here's a report on Exxon Mobil Corp (XOM) based on the data you provided.

## Exxon Mobil Corp (XOM) Stock Analysis

**Company Overview:** Exxon Mobil Corp is an integrated oil and gas company engaged in exploration, production, refining, and marketing of petroleum products.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   **XOM Cumulative Return:** 17.31%
*   **VOO Cumulative Return:** 98.88%
*   **Absolute Divergence (Current):** -80.5%
*   **Divergence Range:** Max: 13.1%, Min: -93.2%
*   **Relative Divergence:** 11.9%

**Analysis:** XOM has significantly underperformed the S&P 500 (VOO) over the period examined. The current divergence is -80.5%, placing it near the lower end of its historical divergence range. The Relative Divergence of 11.9% suggests XOM's performance is in the bottom quantile of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD     | Alpha    | Beta   | Cap(B)  |
|------------|--------|---------|----------|--------|---------|
| 2015-2017  | 9.0%   | 7.1%    | -20.0%   | -0.0   | 360.5   |
| 2016-2018  | 0.0%   | 64.9%   | -18.0%   | 0.0    | 293.9   |
| 2017-2019  | -5.0%  | 64.9%   | -35.0%   | -0.8   | 300.7   |
| 2018-2020  | -39.0% | 64.9%   | -59.0%   | -0.2   | 177.6   |
| 2019-2021  | 4.0%   | 61.1%   | -44.0%   | -0.3   | 263.7   |
| 2020-2022  | 66.0%  | 72.8%   | 64.0%    | -0.2   | 475.4   |
| 2021-2023  | 55.0%  | 72.8%   | 37.0%    | -0.4   | 430.9   |
| 2022-2024  | 4.0%   | 72.8%   | -22.0%   | 0.4    | 463.6   |
| 2023-2025  | -40.0% | 72.3%   | -91.0%   | 0.9    | 477.5   |

**Analysis:**

*   **Alpha:** The consistently negative alpha values (except for 2020-2022 and 2021-2023) indicate that XOM has generally underperformed relative to its risk-adjusted expected return.
*   **Beta:** The beta values fluctuate but generally indicate a relatively low correlation with the market. A beta near 0 suggests the stock's returns are largely independent of market movements. However, the recent period shows a higher beta (0.4 and 0.9), indicating a slightly stronger positive correlation with the market.
*   **CAGR and MDD:** The wide swings in CAGR and high MDD values suggest significant volatility and risk in XOM's performance over these periods.

### 2. Recent Price Action

**Key Numbers:**

*   **Current Price:** 110.79
*   **Previous Close:** 109.93
*   **Change:** 0.78
*   **5-Day Moving Average:** 109.02
*   **20-Day Moving Average:** 111.27
*   **60-Day Moving Average:** 108.24

**Analysis:** The current price is above the 5-day and 60-day moving averages but below the 20-day moving average. This suggests some short-term upward momentum, but the price needs to break above the 20-day moving average to confirm a more sustained uptrend. The price change suggests a recent upward move.

### 3. Technical Indicators and Expected Return

**Key Numbers:**

*   **Market Risk Indicator (MRI):** 0.33 (Medium Risk)
*   **RSI:** 45.82 (Neutral)
*   **PPO:** -0.49 (Bearish)
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-07-22)
*   **Recent (20-day) Relative Divergence Change:** -7.4 (Negative - Short-term decline)
*   **Expected Return (%):** -147.9 (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The MRI of 0.33 indicates a medium level of market risk.
*   **RSI:** The RSI of 45.82 is neutral, suggesting neither overbought nor oversold conditions.
*   **PPO:** The negative PPO (-0.49) suggests a bearish trend.
*   **Hybrid Signal:**  The signal advises a cautious approach, suggesting a 70% cash position and selling a small portion of holdings.  The MRI reinforces this caution.
*   **Relative Divergence Change:** The negative change in relative divergence suggests that XOM's underperformance compared to the S&P 500 has worsened recently.
*   **Expected Return:** The highly negative expected return (-147.9%) suggests a very pessimistic outlook for XOM's long-term performance relative to the S&P 500.

### 4. Recent News & Significant Events

*   **[2025-07-23]:** Exxon Mobil Corp (XOM) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-22]:** Analysts are discussing Exxon Mobil Corp's (XOM) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-24]:** Exxon Mobil Corp (XOM)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-21]:** Market experts highlight both risks and opportunities for Exxon Mobil Corp (XOM), advising investors to monitor recent news and company announcements.

**Analysis:** The news suggests that XOM is currently subject to a number of significant developments impacting its stock price. Monitoring these events is important.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
|------------|------|----------|
| 2025-05-02 | 1.76 | 1.75     |
| 2025-01-31 | 1.67 | 1.77     |
| 2024-11-01 | 1.92 | 1.88     |
| 2024-08-02 | 2.14 | 2.01     |
| 2024-04-26 | 2.06 | 2.2      |

**Analysis:**

*   XOM has generally met or slightly exceeded EPS expectations in recent quarters, with the exception of 2025-01-31 when it missed the estimate. The pattern of meeting expectations indicates consistent operational execution in a turbulent industry environment, contributing to a steady stock performance over the medium term.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $81.06B   | 22.80%        |
| 2024-12-31 | $81.06B   | 21.28%        |
| 2024-09-30 | $87.79B   | 23.23%        |
| 2024-06-30 | $89.99B   | 22.44%        |
| 2024-03-31 | $80.41B   | 23.51%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE    |
|------------|------------|--------|
| 2025-03-31 | $262.72B   | 2.94%  |
| 2024-12-31 | $263.70B   | 2.89%  |
| 2024-09-30 | $268.59B   | 3.21%  |
| 2024-06-30 | $268.40B   | 3.44%  |
| 2024-03-31 | $205.25B   | 4.00%  |

**Analysis:**

*   **Revenue:** Revenue has fluctuated between $80B and $90B, indicating some variability in sales.
*   **Profit Margin:** Profit margins are relatively stable, ranging between 21% and 24%, reflecting solid profitability in its operations.
*   **Equity:** Equity has increased significantly in the most recent quarter, suggesting an improvement in the company's financial position.
*   **ROE:** ROE has shown some decline, indicating that the company is generating slightly less profit from its equity.

### 7. Overall Assessment

Based on the provided data, the analysis suggests:

*   **Underperformance:** XOM has significantly underperformed the S&P 500 and is expected to continue to underperform.
*   **Volatility:** XOM's performance has been volatile, with wide swings in CAGR and high MDD values.
*   **Medium Risk:** The MRI suggests a medium level of market risk.
*   **Mixed Signals:** Recent price action is mixed, with some short-term upward momentum but an overall bearish outlook based on the PPO.
*   **Cautious Stance:** The hybrid signal recommends a cautious approach.
*   **Earnings Consistency:** XOM has consistently met or slightly exceeded earnings expectations, indicating steady operational execution.
*   **Stable Profitability:** Profit margins are relatively stable.
*   **Financial Improvement:** Equity has increased, suggesting an improvement in the company's financial position.

**Overall Recommendation:**

Given the significant underperformance relative to the S&P 500, the negative expected return, and the cautious hybrid signal, a conservative investment approach is warranted. The analysis indicates a higher potential for losses compared to the broader market, and caution should be exercised in the current market climate.

**Disclaimer:** *This analysis is based on the limited data provided and should not be considered financial advice. It is essential to conduct thorough research and consult with a qualified financial advisor before making any investment decisions.*
